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Abstract: Mesenchymal stromal cells (MSCs) have been characterized as an important component of the hematopoietic niche that
plays a role in regulating hematopoietic stem cell (HSC) quiescence, self-renewal, and lineage commitment. Macrophages, one kind of
innate immune cells, are mainly developed from HSCs in niche. However, how MSCs and their subpopulations regulate macrophage
commitment is still unknown. The current study compared the contribution of MSCs and Sca-1+MSCs to macrophage commitment and
further modulation on the function of macrophages. We found that Sca-1+MSCs could promote macrophage commitment through the
M-CSFR gene, and Sca-1+MSCs led macrophage polarization towards the M2 phenotype. Further functional studies indicated that Sca1+MSCs could remarkably promote the phagocytosis capability of macrophages instead of their antigen-presentation ability. These data
demonstrated that Sca-1+MSCs could regulate the commitment and function of macrophages from hematopoietic progenitors, which
provided new evidence for elucidating the role of MSC subpopulations in hematopoiesis.
Key words: Mesenchymal stromal cells, Sca-1+MSCs, macrophages, niche

1. Introduction
Mature blood cells are mainly developed from
hematopoietic stem cells (HSCs) under the regulation of
the hematopoietic microenvironment (niche), which has
been described as an anatomically defined space (Scadden,
2006). The HSC niche is not fully defined, although the
osteolineage and endothelial cells have been demonstrated
to perform crucial roles within the niche. In recent years
the extracellular matrix, mesenchymal stromal cells
(MSCs), sympathetic neurons, and adipocytes have also
been reported to be instrumental to quiescence selfrenewal and differentiation of HSCs (Krause et al., 2013).
MSCs are heterogeneous and capable of differentiating
into adipose, bone, cartilage, muscle, and myeloid
supportive stromal cells (Frenette et al., 2013). Distinct
MSC subpopulations may perform different functions
and may influence differential HSC lineage commitments
(Park et al., 2012; Espagnolle et al., 2014). Variants of
stromal cells, including nestin+ mesenchymal stromal cells
(Méndez-Ferrer et al., 2010), leptin receptor expressing
mesenchymal cells (Ding et al., 2012), Mx1+ stromal
cells (Park et al., 2012), and CXCL12-abundant reticular
* Correspondence: hxbyqh@fmmu.edu.cn

(CAR) cells (Sugiyama et al., 2006) have been proposed
to participate in the regulation of HSCs in bone marrow
(BM). Ablation of either the osteoblasts (Visnjic et al.,
2001, 2004), the CAR cells (Omatsu et al.,2010) or the
nestin+ MSCs (Méndez-Ferrer et al., 2010), using lineage
specific Cre-inducible systems, resulted in HSC reduction
and relocation in BM. Recently, we found that stem cell
antigen-1 (Sca-1) positive cells were one subpopulation
of MSCs that participated in the self-renewal and
differentiation of HSCs in adult mice (Wen et al., 2015).
Nonetheless, further confirmatory functional studies of
Sca-1+MSCs in modulation of hematopoiesis are required.
Macrophages are mainly derived from BM under
the regulation of the HSC niche. They are a typical type
of innate immune cells that act as an early defensive line
in the immune system (Serbina et al., 2008). Following
various stimulations (by pathogens and bacteria),
macrophages would be reprogrammed into a spectrum of
distinct functional phenotypes (Sica and Mantovani, 2012;
Mantovani et al., 2013). Polarized macrophages have been
classified into M1 and M2 subgroups (Gordon and Taylor,
2005). M1 macrophages exert proinﬂammatory activities
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when exposed to interferon (IFN), lipopolysaccharides
(LPSs), tumor necrosis factor (TNF), or granulocytemacrophage colony-stimulating factor (GM-CSF). On the
contrary, M2 macrophages would act as antiinflammatory
factors when triggered by IL-4 and IL-13 (Cho et al.,
2014). Recently, several studies have probed whether
MSCs could guide monocytes/macrophages (M0) to
an enhanced regulatory phenotype via upregulating
the expression of IL-10 (Eggenhofer and Hoogduijn,
2012) and conversely have an effect on the expression of
TNF-α, IL-12, CD86, and HLA class II (Kim and Hematti,
2009; Maggini et al., 2010). In a mouse model of acute
myocardial infarction, the infusion of MSCs gave rise to
an increased level of circulating regulatory M0 (Dayan et
al., 2011). Moreover, macrophages could be adapted to a
regulatory phenotype by the regulation of MSCs in tumor
microenvironment (Nemeth et al., 2009). Nonetheless,
other studies showed MSCs could also induce monocyte/
macrophage polarization from the M0 toward the M1
phenotype associated with increased secretion of IFN-γ,
IL-1, and CD40L (Bernardo and Fibbe, 2013). Therefore,
it is necessary to figure out the function of the MSC
subpopulation in macrophage commitment.
In the present study, we investigated the regulation
of Sca-1+ MSCs on BM derived macrophages and found
that Sca-1+ MSCs were involved in the promotion of
macrophage commitment from progenitors and further
towards the M2 phenotype. Meanwhile, Sca-1+MSCs
enhanced the phagocytic activities of macrophages.
The current observations provided new evidence for
elucidating the role of Sca-1+MSCs in hematopoietic
progenitor development.
2. Materials and methods
2.1. Cells preparation
2.1.1. Mouse BM cells
All C57BL/6 mice protocols were approved by the Animal
Resource Center of the Fourth Military Medical University.
Tibias and femurs were excised from 8–12 week old wildtype C57BL/6 mice maintained in specific pathogen-free
conditions. After cleaning of the muscles and connective
tissue, the bones were gently crushed with a mortar and
pestle in PBS buffer. BM cells were collected, and then
the red blood cells were depleted by ACK lysis buffer and
washed 3 times with PBS before resuspension.
2.1.2. Bone associated MSCs
MSCs were isolated as previously described (Wen et al.,
2015). The bone fragments were digested with collagenase
type I (3 mg/mL, Sigma, Ronkonkoma, NY, USA) for
60 min at 37 °C. The digested mixture was then filtered
through a 70 µm strainer (BD Bioscience, San Jose, CA,
USA), centrifuged at 200 × g at 4 °C, and resuspended in
PBS.
2.1.3. Sca-1+MSCs
Sca-1+MSCs were separated from MSCs by magnetic cell
sorting with EasySep Mouse Sca-1 Positive Selection Kit
(Stem Cell Ltd., Vancouver, Canada), according to the
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manufacturer’s instructions. Sorted cells were washed
once and checked for purity by staining with anti-CD11c/
anti-CD11b/anti-Ter119/anti-Gr1/anti-B220/Sca-1. Some
sorted Sca-1+ cells were equally divided into 6 portions.
Each portion was stained with a single antibody. The
Sca-1+MSCs were maintained in DMEM/F12 medium
(Life Technologies, Grand Island, NY, USA). DMEM/
F12 medium contained 81% DMEM/F12, 15% FBS, 1%
nonessential AA, 50 μM β-ME, and antibiotics.
2.2. Cell cultures
2.2.1. Coculturing cells
The BM cells were cultured alone, or with MSCs/
Sca-1+MSCs in complete RPMI medium (10% FCS,
l-glutamine, 50 μM β-ME) and antibiotics in 24-well flatbottom plates for 8 days. The ratio of binary cocultured
BM/MSCs or BM/Sca-1+ MSCs was 10:1. The same
treatments were used for the coculture of RAW264.7 and
MSCs or Sca-1+MSCs. The suspended cells were collected
on day 8 post coculturing. In some experiments, BM cells
were additionally cultivated with GM-CSF (40 ng/mL,
PeproTech, Rocky Hills, NJ, USA), an inductive agent that
triggers BM cells to macrophages.
2.2.2. Transwell cultures
The Transwell cultures were set up in 24-well culture
plates. Each well contained an insert with a 0.4 µm pore
size membrane (Corning, Corning, NY, USA) to prevent
BM cells from MSCs or Sca-1+MSCs leaking into the lower
chamber, and BM cells were added to the upper chamber.
After 8 days, the upper chamber cells were collected for
extracting mRNA.
2.2.3. Coverslip culture and immunofluorescence
analysis
Three groups (BM, BM/MSCs, and BM/Sca-1+MSCs) were
seeded on coverslips, cultured in 24-well culture plates,
and used to observe the phenotype of macrophages in 8
days. MSCs and Sca-1+MSCs were seeded on coverslips
and cultured in 24-well culture plates. After culturing
for 7 days, MSCs and Sca-1+MSCs on the coverslips were
washed and incubated with 2.5 µg/mL (1:200 diluted by 1X
PBS) FITC antimouse Ly-6A/E (Sca-1) antibody (122506,
Biolegend, San Diego, CA, USA) for 2 h. Subsequently
the coverslips were washed and counterstained with 2
µg/mL DAPI. All coverslips were analyzed by fluorescent
microscopy (Nikon L300, Tokyo, Japan).
2.2.4. Cell lines culture
The mouse macrophage cell line-RAW264.7 (ATCC TIB71) and mouse melanoma cell line-B16 (ATCC, USA)
were cultured in RPMI 1640 supplemented with 10% heatinactivated FBS and 2 mmol/L L-glutamine with 5% CO2
at 37 °C. All the cell culture reagents were bought from
Gibco Life Technologies (Grand Island, NY, USA).
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2.3. Scanning electron microscope analysis
The MSCs and Sca-1+MSCs seeded on the coverslips were
observed by electron scanning microscope (Olympus
N300M, Tokyo, Japan). Macrophages and MSCs or Sca1+MSCs were seeded on the coverslips and cocultured
in 24-well culture plates for 8 days. A scanning electron
microscope was used to observe the phenotype of the
macrophages (Olympus N300M).
2.4. Flow cytometry analysis
All the cells employed in the flow analysis were harvested,
filtered through a nylon filter, and resuspended in
PBS containing 2% fetal bovine serum (Gibco Life
Technologies) and 0.05% NaN3. Cells were counted and
stained by antibodies. The antibodies were purchased from
Biolegend as follows: FITC antimouse CD11c (117306),
APC antimouse CD11b (101212), FITC antimouse Sca-1
(122506), FITC antimouse F4/80 (123108), PE antimouse
MHCII (107608), PE antimouse CD80 (561955), and
APC antimouse CD86 (561964). The other antibodies
were purchased from eBioscience (San, Diego, CA,
USA) as follows: APC antimouse Ter119 (17-5921), APC
antimouse Gr1 (17-5931), and APC antimouse B220 (170452). FACSCalibur (San Jose, CA, USA) was used to
acquire flow cytometric data. All dead cells were excluded
by propidium iodide gating. All data was analyzed using
FlowJo software.
2.5. Reverse transcription polymerase chain reaction
(RT-PCR)
The RNA was extracted from cocultured cells using
an Easy RNA Isolation Kit (QIAGEN, Dusseldorf,
Germany) and reverse transcribed into cDNA with
Sensiscript RT kit (QIAGEN). The cDNA was amplified
by TaqMan (Applied Biosystems, Foster City, CA,
USA) on a PCR System (Bio-Rad, Hercules, CA,
USA) using the following specific primers: M-CSFR-F
5’-ATCTGGACAAAGAGGCCAGC-3’ and M-CSFR-R
5’-TTCACTAGGATGCCGGGGTA-3’;
GADPH-F5’CCATGACAACTTTGGCATTG-3’ and GADPH-R
5’-CCTGCTTCACCACCTTCTTG-3’(Sangon
Biotech
company, Shanghai, China). The thermal cycling
parameters were 30 cycles of 95 °C for 15 s and 58 °C
for 1 min. The RT-PCR products were analyzed with gel
electrophoresis.
2.6. Quantitative real-time PCR (qRT-PCR)
The qRT-PCR was performed and analyzed under the
manual instruction of the Fast Essential DNA Green
Master Kit (Roche Life Science, Basel, Switzerland), BioRad CFX Connect TM instrument, and Bio-Rad CFX
manager software. The reaction mix contained 2X Master
mix, 0.5 μM forward primer, and 0.5 μM reverse primer
in a total volume of 20 μL. The relative mRNA level of
M-CSFR normalized to β-actin and was calculated with
the ΔΔCq method. Primer sequences were as follows:

β-actin, forward: 5’-GAT CAT GTT TGA GAC CTT CAA
CACC -3’ and reverse: 5’- CGT GAG GGA GAG CAT
AGC CC -3’; M-CSFR, forward: 5’-ATG CTG GGA CCC
AGC CTG A-3’; and reverse: 5’-CCT CTT CCA GAT CTT
GCT TA-3’.
2.7. Cytokines analysis
After 7 days of culture of BM alone, or with MSCs /Sca1+MSCs, 100 ng/mL LPS was added to stimulate secreting
cytokines. Supernatants were collected 18 h after LPS
stimulation. The levels of cytokines were measured in
supernatants by ELISA Kits (Roche Life Science), by
calculating the unknown concentrations of the cytokines
from the standard curves.
2.8. Tumor incubation and growth
Adult C57 BL/6 mice were injected subcutaneously with
5 × 106 B16 cells suspended in 0.2 mL of PBS. After
7 days, tumor bearing mice were randomly divided
into groups, and then received injections of 5 × 105 BM
derived macrophages induced by MSCs or Sca-1+ cells,
respectively. BM cells without coculture were injected in
the same amount to serve as controls. Tumor volumes were
determined according to the formula of length × width ×
height × (π / 6) using a digital caliper. Four replications
were done.
2.9. Phagocytosis assay
Tyteca et al. reported that macrophage phagocytosis was
tested by phagocytosing 1 µm green latex beads (2015).
Here, some modifications were made. Green latex beads
were replaced by E. coli bacteria stained with CFSE. E. coli
bacteria were stained with CFSE for 30 min at 37 °C. CFSElabeled E. coli bacteria (250 mg/mL, DH5a) were added to
the macrophages cocultured with bone-associated MSCs
or Sca-1+MSCs for 1 h at 37 °C. Phagocytosis was assessed
by flow cytometry (FACSCalibur, BD).
2.10. Statistical analysis
Statistical analyses were performed using GraphPad Prism
software v.6. If not otherwise stated, the standard error
bar indicated mean ± SD. Replications were done by three
independent experiments. Results were analyzed with
the unpaired Student’s t-test, and P < 0.05 was taken to
indicate significance.
3. Results
3.1. The characterization of Sca-1+MSCs from boneassociated MSCs
Here we analyzed the morphological characterization
of MSCs and Sca-1+MSCs. The immunofluorescence
observations revealed Sca-1+ cells (green fluorescence) in
MSCs and sorted Sca-1+MSCs (Figure 1A). The scanning
electron microscope showed that Sca-1+MSCs exhibited
typical stromal-like growth morphology, which is similar
to that of MSCs (Figure 1B). Subsequently, flow cytometry
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Figure 1. Characterization of bone associated MSCs and Sca-1+MSCs. MSCs andSca-1+MSCs were cultured for 8 days in vitro. (A)
Immunofluorescence analysis ofSca-1+ cells in MSCs and sorted Sca-1+MSCs. Green fluorescence indicated Sca-1+ cells stained with
FITC labeled antibody, and blue fluorescence indicated cells stained with DAPI (magnification = 20×, the bar = 100 μm); (B) SEM
observation of MSCs and sorted Sca-1+MSCs (magnification = 1000×, the bar = 10 μm); (C) percentage of Sca-1+ cells in total MSCs and
sorted Sca-1+MSCs analyzed by FACS; (D) FACS plot of Sca-1+MSCs sorted by other blood lineage markers: CD11c, CD11b, Ter119,
Gr1, and B220, respectively. The blank curves were stained cells with antibodies, and the red curves were unstained cells as the negative
control. *P < 0.05, **P < 0.01, n = 6.

was performed to identify the percentage of Sca-1+MSCs
that were in the total MSCs and the sorted positive cells.
It showed that the Sca-1 positivity rate of MSCs was 7.5%,
and the purity of the Sca-1+MSCs was 83.5% (Figure 1C).
Further, these Sca-1+MSCs were CD11c/CD11b/Ter119/
Gr1/B220 negative (Figure 1D). All together, these data
suggested that Sca-1+ cells were stromal cells.
3.2. MSCs were a positive factor in macrophage
commitment
Macrophages are mainly originated from HSCs within a
specialized niche (Cho et al., 2014). MSCs are the critical
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components in the HSC niche and play a critical role in
macrophage development (Bernardo and Fibbe, 2013).
We wanted to know whether a single subpopulation of
MSCs could contribute to macrophage commitment from
hematopoietic progenitors. Therefore, the isolated BM
cells were separately cocultured with an MSC mixture
and Sca-1+MSCs. After 8 days, flow cytometry was
performed to sort the mature macrophages by CD11b and
F4/80 markers. The results showed that approximately
equal numbers of mature macrophages (CD11b+/F4/80+)
were derived from Sca-1+MSCs and MSCs administered
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BM cells (30.1 ± 0.3% versus 27.6 ± 0.3%, Figure 2A).
The numbers were significantly higher than the result
derived from the bone marrow cells without stimuli (0.6
± 0.2%) (Figures 2A and 2B). To evaluate whether the
MSC mixture and the Sca-1+MSCs contributed to mature
macrophages or not, a mature RAW264.7 cell line was
respectively cocultured with MSCs and Sca-1+MSCs. The
results showed that there were slight effects of MSCs or
Sca-1+MSCs on mature macrophages (RAW264.7: 76.8
± 0.5%, RAW264.7/MSC: 88.7 ± 0.3%, and RAW264.7/
Sca-1: 86.5 ± 0.4%) (Figures 2C and 2D). Taken together,
these results suggest that the bone associated MSCs or

C

RAW264.7

RAW264.7+MSC
88.7

RAW264.7+Sca -1

D

86.5

ns

F4/ 80

76.8

Sca-1+MSCs could efficiently promote the differentiation
of HSCs rather than mature cell lines.
To further track the involved gene in the macrophages
educated by MSCs, we tried to detect a key molecular
marker, the M-CSF receptor (M-CSFR), which is a specific
molecular marker of the M0 lineage (Xie et al., 2001).
The RT-PCR results revealed that the mRNA levels of
M-CSFR were increased in the BM/MSCs group and BM/
Sca-1+MSCs group by semi-RT-PCR (Figure 2E). The
qRT-PCR results showed that the mRNA level of M-CSFR
in the BM/Sca-1+MSCs group was significantly higher
than that in the other groups (Figure 2F). Above all, the

CD11b

E

F
*

M - CSFR

ns

GADPH

Figure 2. Macrophage commitment from BM cells under the stimulation of MSCs or Sca-1+MSCs. BM cells or RAW264.7 cell line were
cocultured with MSCs or Sca-1+ cells, respectively, for 8 days in vitro. (A) The detached cells in macrophage cultures were collected and
stained with CD11b and F4/80 directed antibodies and assessed by flow cytometry; (B) quantitative analyses of surface makers staining
data; (C) RAW264.7 cells were stained with CD11b and F4/80 directed antibodies; (D) quantitative analyses of RAW264.7 surface
makers staining (numbers in A and C are percentages); (E) the expression of M-CSFR in BM derived macrophages by semi-RT-PCR
(the expression of GADPH was used as control); (F) the mRNA level of M-CSFR by qRT-PCR (the expression of β-actin was used as
control). Data are shown as mean ± SD for 4 independent experiments. *P < 0.05, **P < 0.01, ns indicates no significant difference.
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used a scanning electron microscope. The observations
suggested that M2-like macrophage cells presented in BM
cells with stimulation of MSCs or Sca-1+MSCs (Figure
3A), while M1-like macrophage cells presented in BM
cells with the stimulation of LPSs. These results indicated
that MSCs or Sca-1+MSCs could enhance BM derived
macrophage polarization towards the M2 phenotype. In
the process of polarization in tumor progression, M1 and

data suggested that Sca-1+MSCs efficiently promoted the
differentiation of HSCs towards macrophages, which were
associated with the upregulation of M-CSFR expression.
3.3. Bone associated MSCs biased macrophage polarizing
toward the M2 phenotype
M1 macrophages take on a fibroblast-like appearance,
while M2 macrophages take on a fried egg-like appearance
(Mills et al., 2000). To test the morphological changes, we
A

BM+MSC+LPS

BM+LPS

BM+Sca - 1+LPS

M2

M1

M2
200 μm
M2

M2
M1
100 μm

B

*

**

**

pg/mL

*

pg/mL

IL-10

C

Figure 3. Cytokine concentration in macrophage culture. BM cells were cocultured with MSCs or Sca-1+MSCs for 8 days in vitro
before stimulation with LPSs. The concentrations of IL-12p70 and IL-10 were evaluated by ELISA. (A) Morphological comparison of
BM derived macrophages under various stimulation using scanning electron microscope (magnification = 1000× (above, the bar = 200
μm) or 2000× (below, the bar = 100 μm)); (B) the concentration of IL-12p70 in the supernatant of BM cells under various stimulations
evaluated by ELISA; (C) the concentration of IL-10 secreted by cells under identical treatment as above. Data are shown as mean ± SD
for 4 independent experiments.*P < 0.05, **P < 0.01.
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M2 macrophages secrete different levels of cytokines. M1
macrophages are IL-12high, IL-10low, and IL-23high, while
the M2 macrophages are IL-12low, IL-10high, and IL-23low
(Fleetwood et al., 2007). Here ELISA was employed to
measure the concentration of IL-12p70 and IL-10 in the
supernatant of cocultured cells under the stimulation of
LPSs. The concentration of IL-12p70 in the BM group was
nearly 800 pg/mL, and was less than 200 pg/mL in those
cells postcocultured with the MSC mixture or the Sca1+MSCs (Figure 3B). On the contrary, the concentration
of IL-10 was increased to 400 pg/mL in the supernatant
of cocultured cells, and was 130 pg/mL in that of the
BM group (Figure 3C). Meanwhile, we found that the
concentrations of IL-12p70 and IL-10 were less than 60
pg/mL in the supernatant of cultured cells (MSCs, Sca-1,
BM, BM + MSCs, BM + Sca-1) without the stimulation of
LPSs (Supplemental Figure 1). These results indicated that
MSCs or Sca-1+ MSCs promoted BM derived macrophages
to develop into the M2 phenotype.
3.4. MSC educated M2 macrophages promoted tumor
growth
The M1 phenotype is characterized by the expression
of high levels of proinflammatory cytokines and
strong microbicidal and tumoricidal activities. By
contrast, the M2 phenotype macrophages mainly exert
immunoregulatory functions, and are involved in parasite
containment, tissue remodeling, and tumor development
(Sica and Mantovani, 2012). To ensure the effects of the
M2 macrophages educated by MSCs, we used BM derived
macrophages to treat tumor bearing mice that received a
subcutaneous injection of B16 melanoma cells. We found
that tumors grew faster and bigger in the MSCs or Sca1+MSCs group than in the BM group (Figures 4A and 4B).
B

C

*

*

Tumor volume (mm3)

Tumor volume (mm3)

A

The difference between the Sca-1+MSCs group and the BM
group was significant (Figure 4C). These data indicated
that BM derived macrophages educated by MSCs could
promote tumor growth.
3.5. MSCs increased the phagocytosis capability of
macrophages
Macrophages are professional phagocytic cells that
recognize and engulf pathogens such as bacteria and
viruses (Serbina et al., 2008). In this study, we analyzed
whether BM derived macrophages cultured in the presence
of Sca-1+MSCs displayed a higher ability to phagocyte
bacteria. Experiments were performed by incubating BM
derived macrophages and Sca-1+MSCs with CFSE-labeled
E. coli. Phagocytosis was evaluated by analyzing the
macrophages with CFSE fluorescence. The data showed
CFSE fluorescence in 32 ± 0.2% of the macrophages in the
BM group, whereas it was in 59 ± 0.3% of the macrophages
in the MSC group, and in 53 ± 0.4% in the Sca-1+MSC
group (Figure 5A). The difference between the BM group
and the MSC group (or the Sca-1+MSC group) was
significant (Figure 5B). These data indicated that MSCs or
Sca-1+MSCs could promote the phagocytosis capability of
BM derived macrophages.
3.6. MSCs downregulated the antigen-presenting signal
of macrophages
Classically, macrophages are working as semiprofessional
antigen-presenting cells, expressing antigen-presenting
molecules, MHCII, CD80, and CD86 on the cell surface
(Gordon and Taylor, 2005). Thus, flow cytometry was
used to detect the efficiency of the antigen-presenting
molecules CD80, CD86, and MHCII, on the BM derived
macrophages under LPS stimulation (Figures 6A–6F). The
results suggested that MHCII expression in macrophages

*

**

Figure 4. The effecof BM derived macrophages on tumor growth. B16 melanoma tumor-bearing mice were injected with BM derived
macrophages. (A) rowth curves of tumor in tumor-bearing mice. Tumor volume was determined as length × width × height × (π / 6)
using a digital caliper (n = 4). *P < 0.05, **P < 0.01. (B) Examples of tumor from mice treated with BM derived macrophages with MSCs
or Sca-1+MSCs plus GM-CSF administration. (C) Quantitative analysis of tumor volumes in different treatment groups. Data are shown
as mean ± SD for 4 independent experiments.*P < 0.05, **P < 0.01.
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Figure 5. Phagocytosis capacity of BM derived macrophages. Bacterial phagocytic capabilities of BM derived macrophage were detected
after BM cells were cocultured with MSCs or Sca-1+MSCs for 8 days in vitro. (A) The percentage of macrophages containing CFSElabeled E. coli was analyzed by flow cytometry. (B) Quantitative analysis of macrophages containing CFSE-labeled E. coli. Data are
represented as mean ± SD for 4 independent experiments *P < 0.05, **P < 0.01.
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Figure 6. The expression of antigen-presenting molecules of BM derived macrophages under LPS stimulation. (A) FACS plots of
MHC II+ BM derived macrophages with diverse treatments; (B) statistical analysis of (A); (C) percentage of CD86+ macrophages under
identical treatments as shown in (A); (D) quantitative analysis of CD86+ macrophages, according to (C); (E) percentage of CD80+
macrophages under identical treatments as shown in (A); (F) quantitative analysis of CD80+ macrophages, according to (E). Data are
represented as mean ± SD based on 4 independent experiments. *P < 0.05, **P < 0.01.
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was significantly downregulated in the MSC group
(31.0 ± 0.3%) or the Sca-1+MSC group (20.7 ± 0.3%) in
comparison with that in the BM group (50.2 ± 0.3%)
(Figures 6A and 6B). The percentages of CD80 expression
and CD86 expression in macrophages were 40.2 ± 0.3%
and 31.4 ± 0.2%, respectively, in the BM group (Figures
6C and 6E, left panel), while the levels of CD86 expression
and CD80 expression in macrophages in the MSC group
were 27.5 ± 0.2% and 28.2 ± 0.3%, respectively (Figures 6C
and 6E, middle panel). A yet lower level of those was found
in the Sca-1+MSC group (Figures 6C and 6E, right panel).
The differences of CD80/86 expression between the BM
group and the MSC group (or the Sca-1+MSC group) were
significant (Figures 6D and 6F). These results indicated
that the expression of antigen-presenting molecules in
macrophages could be significantly inhibited by MSCs and
Sca-1+MSCs.
4. Discussion
We once confirmed that Sca-1+ MSCs were important players
in the hematopoietic niche, and found that Sca-1+MSCs
decreased the severity of acute GVHD and prolonged the
survival of allogeneic HCT recipients (Wen et al., 2015). We
conducted the current study to further explore the function
of Sca-1+MSCs in hematopoietic lineage commitment.
Our data indicated that bone-associated MSCs and Sca1+MSCs promoted macrophage commitment from BM and
polarized macrophages towards the M2 phenotype. We
further provided evidence that Sca-1+MSCs might impair
the antigen-presenting activity capability of macrophages,
and augment their phagocytic activity. The present study
pioneered the role of Sca-1+MSCs in the commitment and
function of macrophages.
The role of MSCs in enhancing HSC bias toward
macrophages has attracted intensive attention. Due to
MSCs being notoriously heterogeneous, several groups
sought to explore the various functions of different MSC
subpopulations. For instance, bone regeneration and
vascular smooth muscle commitment were investigated
(Park et al., 2012; Espagnolle et al., 2014). In this study,
flow cytometric detection was performed and showed that
an increased percentage of CD11b+/F4/80+ BM derived
macrophages were promoted by the bone-associated
MSCs and their Sca-1+ subset. A fundamental question
in our study was whether the Sca-1+ subpopulation could
function similarly in the modulation of macrophage
commitment, and the answer was certainly positive.
Even the flow cytometric analysis showed an increased
percentage of CD11b+/F4/80+ macrophage output in the
BM treated with Sca-1+MSCs.
The M-CSF/M-CSFR signal is reported as a central factor
in survival, proliferation, differentiation, and maturation
of the M0 lineage (Gordon, 2003). In the present study,

we observed that Sca-1+MSCs could effectively promote a
larger number of HSCs to differentiate into macrophages
with a higher expression of M-CSFR than those without an
extra stimulation. These results showed that Sca-1+MSCs
employed M-CSFR to promote macrophage commitment.
Previous studies reported that the inhibition of M-CSFR
may have utility in cancer (Hume and MacDonald, 2012;
Ries et al., 2014). One kind of M-CSFR inhibitor, RG7155,
strongly reduced tumor-associated macrophages, which
translated into objective clinical responses in diffuse-type
giant cell tumor patients (Ries et al., 2014). Therefore,
the inhibition of Sca-1+MSCs in tumor may inhibit the
tumor-associated macrophages, which may be a strategy
for cancer therapy.
Macrophages are important effectors in immune
responses. Activated macrophages could be polarized
into M1 and M2 subgroups with proper stimuli (Gordon
and Taylor, 2005). Here, we showed that the secretion of
antiinflammatory cytokine IL-10 and proinflammatory
cytokines IL-12 could be enhanced and inhibited,
respectively, by BM derived macrophages under the
stimulation of MSCs or Sca-1+MSCs. Previous studies
reported that M1 macrophages highly secrete IL-12 and
IL-23, while M2 macrophages secrete low levels of IL-12
and high levels of IL-10 (Barcellos-de-Souza et al., 2013).
Our data showed that MSCs or Sca-1+MSCs could promote
BM cells to develop towards M2 macrophages. M2
macrophages are mainly involved in parasite containment
and tissue remodeling (Li et al., 2015). Moreover, tumorassociated macrophages were M2 macrophages; they
regulated the tumor microenvironment and precipitated
tumor growth and progression (Mantovani et al., 2002).
Our results showed that macrophages cocultured with
MSCs and Sca-1+MSCs promoted melanoma growth
in mice, which further supported the finding that
macrophages cocultured with MSCs and Sca-1+MSCs
were M2 macrophages.
The capability of bacterial phagocytosis of the
macrophages cocultured with MSCs or Sca-1+MSCs
was increased. Kim and Hematti (2009) also found that
macrophages cocultured with MSCs had a higher level of
phagocytic activity. However, the expressions of specific
antigen-presenting markers, such as MHCII, CD80, and
CD86 were reduced in the BM + MSC group or the BM
+ Sca-1+ MSC group versus those in the BM group. Thus,
we assumed that MSCs or Sca-1+MSCs could inhibit
the antigen-presenting signal of macrophages. This was
consistent with our previous findings that Sca-1+MSCs
inhibited CD80/86 expression to suppressed GVHD (Wen
et al., 2015), but further antigen-presenting investigations
are needed.
It was reported that the clinical indications for
human MSCs are considerably wide, ranging from
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cell replacement in degenerative diseases to immunerelated diseases (Chen et al., 2011). Macrophages are
a typical type of innate immune cells that act as an
early defensive line in the immune system (Serbina et
al., 2008). Recently, several studies have demonstrated
that MSCs modulate macrophage differentiation and
function in humans (Zhang et al., 2010; Francois et al.,
2012; Nakajima et al., 2012), which is consistent with
our results. After spinal cord injury, transplantation of
MSCs promoted an alternative pathway of macrophage
activation and functional recovery (Nakajima, et al.,
2012). Human MSC suppression correlated with cytokine
induction of indoleamine 2,3-dioxygenase (IDO) and
MSC IDO activity was implicated in the differentiation
of monocytes into M2 immunosuppressive macrophages
(Francois et al., 2012). MSCs from human gingiva could
elicit M2 polarization, which significantly enhanced
wound repair (Zhang et al., 2010). However, previous
preclinical experiments or clinical trials for investigating
the effects of MSCs on macrophages have predominantly
used MSC mixtures. The heterogeneity of MSC mixtures

containing various subpopulations may be the reason for
contradictory outcomes. Therefore, we should consider
that when studying the effects of MSC subpopulations on
macrophages in preclinical or clinical studies.
In conclusion, the presented data demonstrated that
Sca-1+MSCs modulate macrophage commitment and
function. BM derived macrophages could be educated to
the M2 phenotype under the regulation of MSCs or Sca1+MSCs. The polarized macrophages exhibited increased
phagocytic activities. This may provide a novel approach
to elucidate the function of MSCs and Sca-1+MSCs in
modulating hematopoiesis.
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Supplemental Figure 1. Cytokine concentrated in different cultured cells. Five groups (MSCs, Sca-1+MSCs, BM cells, BM + MSCs,
and BM + Sca-1+MSCs) were cultured for 8 days in vitro. The concentrations of IL-12p70 and IL-10 were evaluated by ELISA. (A) The
concentration of IL-12p70 in the supernatant of different cells evaluated by ELISA. (B) The concentration of IL-10 secreted by cells
under identical treatment as (A). Data are shown as mean ± SD for 4 independent experiments. *P < 0.05, **P < 0.01.
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